Pharmacoepidemiology of bleeding events after use of r-alteplase or streptokinase in acute myocardial infarction.


OBJECTIVE To determine in nonresearch, general medical practice conditions the comparative incidence and types of bleeding complications after the use of streptokinase (SK) and r-alteplase (recombinant tissue plasminogen activator, rt-PA) to treat acute myocardial infarction (AMI). DESIGN Retrospective medical record review of concurrently treated… (More)


  • Presentations referencing similar topics